US Stock MarketDetailed Quotes

NKTR Nektar Therapeutics

Watchlist

1.1100
-0.0500-4.31%

Close Sep 26 16:00 ET

1.1300
+0.0200+1.80%

Post 16:10 ET

204.33MMarket Cap-1233P/E (TTM)

Nektar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

26.82%-37.7M

7.76%-47.89M

36.64%-192.61M

18.47%-47.05M

49.18%-42.12M

31.30%-51.52M

41.29%-51.92M

26.33%-304.01M

61.92%-57.7M

18.04%-82.89M

Net income from continuing operations

-2.43%-52.36M

73.14%-36.8M

25.03%-276.06M

29.50%-42.08M

22.37%-45.84M

67.86%-51.12M

-51.58%-137.02M

29.71%-368.2M

59.02%-59.69M

54.47%-59.05M

Operating gains losses

----

117.41%6.4M

----

-558.10%-36.75M

-968.41%-3.33M

--0

Depreciation and amortization

-32.64%1.46M

-30.19%1.61M

-40.02%7.82M

-48.08%1.65M

-36.68%1.7M

-37.05%2.17M

-38.28%2.3M

-7.89%13.03M

-7.39%3.18M

-26.05%2.68M

Deferred tax

311.11%57K

97.90%-38K

-105.17%-140K

-36.71%1.71M

---15K

---27K

---1.81M

2,754.90%2.71M

--2.71M

--0

Other non cash items

-11.72%-7.32M

4.01%-13.04M

-21.30%-43.59M

-7.37%-11.19M

-1.39%-12.26M

31.85%-6.55M

-257.03%-13.59M

-436.44%-35.93M

-180.28%-10.43M

-1,885.67%-12.09M

Change In working capital

215.42%10.8M

-167.62%-6.62M

-4,124.39%-19.8M

41.35%-4.73M

88.36%-3.23M

-142.89%-9.36M

-117.05%-2.47M

102.14%492K

84.40%-8.07M

-648.17%-27.77M

-Change in receivables

45.84%2.42M

-180.78%-2.41M

-71.07%4.78M

-82.00%999K

43.05%-869K

-91.79%1.66M

138.64%2.99M

33.19%16.51M

121.86%5.55M

-1,140.65%-1.53M

-Change in inventory

128.12%212K

42.42%-1.14M

120.55%699K

838.62%1.07M

213.36%2.37M

52.58%-754K

-570.38%-1.99M

-568.17%-3.4M

69.21%-145K

-192.44%-2.09M

-Change in payables and accrued expense

162.14%6.62M

111.92%868K

-18.78%-20.01M

77.82%-3.16M

105.85%1.08M

-742.25%-10.65M

-142.41%-7.28M

51.34%-16.84M

54.61%-14.26M

-714.67%-18.48M

-Change in other current assets

20.86%2.79M

-117.46%-976K

-48.12%3.58M

-142.40%-867K

-24.80%-3.45M

-51.48%2.31M

95.22%5.59M

367.05%6.91M

160.15%2.05M

74.32%-2.77M

-Change in other working capital

35.89%-1.24M

-65.62%-2.96M

-230.22%-8.85M

-120.53%-2.77M

18.84%-2.36M

-541.53%-1.93M

-199.94%-1.79M

-214.53%-2.68M

93.36%-1.26M

-159.50%-2.91M

Cash from discontinued investing activities

Operating cash flow

26.82%-37.7M

7.76%-47.89M

36.64%-192.61M

18.47%-47.05M

49.18%-42.12M

31.30%-51.52M

41.29%-51.92M

26.33%-304.01M

61.92%-57.7M

18.04%-82.89M

Investing cash flow

Cash flow from continuing investing activities

-32.53%16.98M

-52.56%19.26M

-61.85%139.56M

-56.56%17.38M

-49.36%56.41M

-70.09%25.17M

-68.84%40.6M

80.41%365.84M

-66.71%40.01M

13,521.08%111.4M

Net PPE purchase and sale

-14.81%-186K

63.74%-157K

-94.95%380K

-101.87%-237K

769.61%1.21M

79.23%-162K

89.70%-433K

150.17%7.52M

315.13%12.68M

93.84%-181K

Net investment purchase and sale

-32.23%17.17M

-52.68%19.42M

-61.16%139.18M

-35.53%17.62M

-50.53%55.2M

-70.17%25.33M

-69.49%41.03M

64.54%358.32M

-78.33%27.33M

5,198.01%111.58M

Cash from discontinued investing activities

Investing cash flow

-32.53%16.98M

-52.56%19.26M

-61.85%139.56M

-56.56%17.38M

-49.36%56.41M

-70.09%25.17M

-68.84%40.6M

80.41%365.84M

-66.71%40.01M

13,521.08%111.4M

Financing cash flow

Cash flow from continuing financing activities

5.56%19K

42M

-98.01%30K

-88.35%12K

-96.15%18K

-95.84%1.51M

-95.96%103K

Net common stock issuance

--0

---3M

----

--0

----

Proceeds from stock option exercised by employees

5.56%19K

--30M

-96.04%30K

-88.35%12K

--0

-96.15%18K

--0

-97.72%758K

-94.28%103K

--0

Net other financing activities

--0

--15M

----

-75.00%750K

--0

Cash from discontinued financing activities

Financing cash flow

5.56%19K

--42M

-98.01%30K

-88.35%12K

--0

-96.15%18K

--0

-95.84%1.51M

-95.96%103K

--0

Net cash flow

Beginning cash position

-36.79%48.64M

-60.02%35.28M

249.86%88.23M

-38.61%64.92M

-34.58%50.73M

13.18%76.96M

249.86%88.23M

-87.32%25.22M

95.79%105.76M

-49.10%77.55M

Current changes in cash

21.39%-20.7M

218.17%13.37M

-183.70%-53.01M

-68.61%-29.65M

-49.87%14.29M

-373.69%-26.33M

-126.45%-11.32M

136.47%63.34M

38.91%-17.59M

129.00%28.51M

Effect of exchange rate changes

-100.93%-1K

-117.78%-8K

118.96%62K

-85.45%8K

66.78%-98K

252.86%107K

364.71%45K

-255.43%-327K

650.00%55K

-1,080.00%-295K

End cash Position

-44.92%27.94M

-36.79%48.64M

-60.02%35.28M

-38.61%64.92M

-34.58%50.73M

13.18%76.96M

249.86%88.23M

95.79%105.76M

Free cash flow

26.69%-37.89M

8.22%-48.05M

37.53%-193.47M

18.78%-47.28M

49.25%-42.15M

31.79%-51.69M

43.49%-52.35M

27.58%-309.68M

63.02%-58.22M

20.18%-83.07M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	26.82%-37.7M	7.76%-47.89M	36.64%-192.61M	18.47%-47.05M	49.18%-42.12M	31.30%-51.52M	41.29%-51.92M	26.33%-304.01M	61.92%-57.7M	18.04%-82.89M
Net income from continuing operations	-2.43%-52.36M	73.14%-36.8M	25.03%-276.06M	29.50%-42.08M	22.37%-45.84M	67.86%-51.12M	-51.58%-137.02M	29.71%-368.2M	59.02%-59.69M	54.47%-59.05M
Operating gains losses	----	----	117.41%6.4M	----	----	----	----	-558.10%-36.75M	-968.41%-3.33M	--0
Depreciation and amortization	-32.64%1.46M	-30.19%1.61M	-40.02%7.82M	-48.08%1.65M	-36.68%1.7M	-37.05%2.17M	-38.28%2.3M	-7.89%13.03M	-7.39%3.18M	-26.05%2.68M
Deferred tax	311.11%57K	97.90%-38K	-105.17%-140K	-36.71%1.71M	---15K	---27K	---1.81M	2,754.90%2.71M	--2.71M	--0
Other non cash items	-11.72%-7.32M	4.01%-13.04M	-21.30%-43.59M	-7.37%-11.19M	-1.39%-12.26M	31.85%-6.55M	-257.03%-13.59M	-436.44%-35.93M	-180.28%-10.43M	-1,885.67%-12.09M
Change In working capital	215.42%10.8M	-167.62%-6.62M	-4,124.39%-19.8M	41.35%-4.73M	88.36%-3.23M	-142.89%-9.36M	-117.05%-2.47M	102.14%492K	84.40%-8.07M	-648.17%-27.77M
-Change in receivables	45.84%2.42M	-180.78%-2.41M	-71.07%4.78M	-82.00%999K	43.05%-869K	-91.79%1.66M	138.64%2.99M	33.19%16.51M	121.86%5.55M	-1,140.65%-1.53M
-Change in inventory	128.12%212K	42.42%-1.14M	120.55%699K	838.62%1.07M	213.36%2.37M	52.58%-754K	-570.38%-1.99M	-568.17%-3.4M	69.21%-145K	-192.44%-2.09M
-Change in payables and accrued expense	162.14%6.62M	111.92%868K	-18.78%-20.01M	77.82%-3.16M	105.85%1.08M	-742.25%-10.65M	-142.41%-7.28M	51.34%-16.84M	54.61%-14.26M	-714.67%-18.48M
-Change in other current assets	20.86%2.79M	-117.46%-976K	-48.12%3.58M	-142.40%-867K	-24.80%-3.45M	-51.48%2.31M	95.22%5.59M	367.05%6.91M	160.15%2.05M	74.32%-2.77M
-Change in other working capital	35.89%-1.24M	-65.62%-2.96M	-230.22%-8.85M	-120.53%-2.77M	18.84%-2.36M	-541.53%-1.93M	-199.94%-1.79M	-214.53%-2.68M	93.36%-1.26M	-159.50%-2.91M
Cash from discontinued investing activities
Operating cash flow	26.82%-37.7M	7.76%-47.89M	36.64%-192.61M	18.47%-47.05M	49.18%-42.12M	31.30%-51.52M	41.29%-51.92M	26.33%-304.01M	61.92%-57.7M	18.04%-82.89M
Investing cash flow
Cash flow from continuing investing activities	-32.53%16.98M	-52.56%19.26M	-61.85%139.56M	-56.56%17.38M	-49.36%56.41M	-70.09%25.17M	-68.84%40.6M	80.41%365.84M	-66.71%40.01M	13,521.08%111.4M
Net PPE purchase and sale	-14.81%-186K	63.74%-157K	-94.95%380K	-101.87%-237K	769.61%1.21M	79.23%-162K	89.70%-433K	150.17%7.52M	315.13%12.68M	93.84%-181K
Net investment purchase and sale	-32.23%17.17M	-52.68%19.42M	-61.16%139.18M	-35.53%17.62M	-50.53%55.2M	-70.17%25.33M	-69.49%41.03M	64.54%358.32M	-78.33%27.33M	5,198.01%111.58M
Cash from discontinued investing activities
Investing cash flow	-32.53%16.98M	-52.56%19.26M	-61.85%139.56M	-56.56%17.38M	-49.36%56.41M	-70.09%25.17M	-68.84%40.6M	80.41%365.84M	-66.71%40.01M	13,521.08%111.4M
Financing cash flow
Cash flow from continuing financing activities	5.56%19K	42M	-98.01%30K	-88.35%12K	0	-96.15%18K	0	-95.84%1.51M	-95.96%103K	0
Net common stock issuance	--0	---3M	----	----	----	--0	--0	----	----	----
Proceeds from stock option exercised by employees	5.56%19K	--30M	-96.04%30K	-88.35%12K	--0	-96.15%18K	--0	-97.72%758K	-94.28%103K	--0
Net other financing activities	--0	--15M	----	----	----	----	----	-75.00%750K	--0	--0
Cash from discontinued financing activities
Financing cash flow	5.56%19K	--42M	-98.01%30K	-88.35%12K	--0	-96.15%18K	--0	-95.84%1.51M	-95.96%103K	--0
Net cash flow
Beginning cash position	-36.79%48.64M	-60.02%35.28M	249.86%88.23M	-38.61%64.92M	-34.58%50.73M	13.18%76.96M	249.86%88.23M	-87.32%25.22M	95.79%105.76M	-49.10%77.55M
Current changes in cash	21.39%-20.7M	218.17%13.37M	-183.70%-53.01M	-68.61%-29.65M	-49.87%14.29M	-373.69%-26.33M	-126.45%-11.32M	136.47%63.34M	38.91%-17.59M	129.00%28.51M
Effect of exchange rate changes	-100.93%-1K	-117.78%-8K	118.96%62K	-85.45%8K	66.78%-98K	252.86%107K	364.71%45K	-255.43%-327K	650.00%55K	-1,080.00%-295K
End cash Position	-44.92%27.94M	-36.79%48.64M	-60.02%35.28M	-60.02%35.28M	-38.61%64.92M	-34.58%50.73M	13.18%76.96M	249.86%88.23M	249.86%88.23M	95.79%105.76M
Free cash flow	26.69%-37.89M	8.22%-48.05M	37.53%-193.47M	18.78%-47.28M	49.25%-42.15M	31.79%-51.69M	43.49%-52.35M	27.58%-309.68M	63.02%-58.22M	20.18%-83.07M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data